Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The joint analysis of brain atrophy measured with magnetic resonance imaging (MRI) and hypometabolism measured with positron emission tomography with fluorodeoxyglucose (FDG-PET) is of primary importance in developing models of pathological changes in Alzheimer's disease (AD). Most of the current multimodal analyses in AD assume a local (spatially overlapping) relationship between MR and FDG-PET intensities. However, it is well known that atrophy and hypometabolism are prominent in different anatomical areas. The aim of this work is to describe the relationship between atrophy and hypometabolism by means of a data-driven statistical model of non-overlapping intensity correlations. For this purpose, FDG-PET and MRI signals are jointly analyzed through a computationally tractable formulation of partial least squares regression (PLSR). The PLSR model is estimated and validated on a large clinical cohort of 1049 individuals from the ADNI dataset. Results show that the proposed non-local analysis outperforms classical local approaches in terms of predictive accuracy while providing a plausible description of disease dynamics: early AD is characterised by non-overlapping temporal atrophy and temporo-parietal hypometabolism, while the later disease stages show overlapping brain atrophy and hypometabolism spread in temporal, parietal and cortical areas.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4827392PMC
http://dx.doi.org/10.1038/srep22161DOI Listing

Publication Analysis

Top Keywords

atrophy hypometabolism
12
alzheimer's disease
8
intensity correlations
8
brain atrophy
8
atrophy
5
hypometabolism
5
multimodal image
4
image analysis
4
analysis alzheimer's
4
disease
4

Similar Publications

Preliminary observations of glucose metabolism dysregulation in pediatric Huntington's disease.

Front Neurol

August 2025

Department of Pediatric Neuroscience, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy.

Background: Pediatric Huntington's disease (PHD), a rare and severe form of juvenile-onset Huntington's disease (JOHD), is associated with highly expanded CAG repeats in the gene and a rapidly progressive neurodegenerative course. Recent studies have suggested that glucose metabolism may be impaired in PHD due to reduced expression of glucose transporters in the brain, resembling aspects of GLUT1 Deficiency Syndrome (GLUT1DS).

Methods: We investigated glucose metabolism in two pediatric patients with genetically confirmed PHD (CAG repeats: 76 and 79) referred to our tertiary care center.

View Article and Find Full Text PDF

The precuneus is a central hub of the human brain, and its morphology displays a noticeable individual variability. It is larger in humans than in other primates, and it is affected by atrophy and hypometabolism in the early stages of Alzheimer's disease (AD). In this study, we compare its general morphology in normal aging subjects and AD patients, considering its geometry through shape analysis, and the atrophy at its boundary by quantifying the intersulcal spacing.

View Article and Find Full Text PDF

Molecular imaging based spatiotemporal dynamics progression of brain glucose metabolism in multiple system atrophy.

Eur J Nucl Med Mol Imaging

August 2025

Department of Nuclear Medicine and PET-CT Center, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China.

Objective: Multiple system atrophy (MSA) is a progressive neurodegenerative disorder with complex clinical manifestations, which is essential for patient management and mechanistic understanding of MSA. In this study, we aimed to use disease progression modeling (SuStaIn model) to elucidate the in vivo spatiotemporal progression patterns of brain glucose metabolism in MSA patients, and investigate the differential profiles of clinical characteristics and dopaminergic function among the identified progression-related subtypes.

Methods: A total of 192 participants (117 MSA patients [70 MSA-P, 47 MSA-C] and 75 healthy controls) who underwent [F]FDG PET scans, with 82 MSA patients additionally receiving [F]FP-CIT PET imaging were retrospectively enrolled.

View Article and Find Full Text PDF

[Longitudinal follow-up in patients with dementia with Lewy bodies: clinical and multimodal imaging characteristics].

Zhonghua Yi Xue Za Zhi

August 2025

Department of Neurology, the Second Medical Centre and National Clinical Research Center for Geriatric Disease, Chinese PLA General Hospital, Beijing 100853, China.

To characterize the clinical and imaging features of Dementia with Lewy Bodies (DLB) through long-term follow-up. This study analyzed clinical and multimodal imaging data, including magnetic resonance imaging (MRI), dopamine transporter (DAT), C Pittsburgh compound B (C-PIB), and F-fluorodeoxyglucose (F-FDG) positron emission tomography (PET), from 11 probable DLB patients at the first and second medical center of PLA General Hospital from March 2012 to February 2025. Patients were longitudinally assessed for the following parameters: time from disease onset to bedridden status, time from onset to death, annual cognitive decline rate (measured by mini-mental state examination, MMSE), extent of cerebral atrophy, regions of hypometabolism, and areas of reduced DAT availability.

View Article and Find Full Text PDF

Metabolic network remodeling and AI-driven precision diagnostics in geriatric Parkinson's disease: Advances in multimodal imaging.

Arch Gerontol Geriatr

November 2025

Xinjiang Medical University,No.567, Shangde North Road, Shuimogou District,Urumqi City, Xinjiang Uygur Autonomous Region, Urumchi 830000, PR China; The Second Affiliated Hospital of Xinjiang Medical University, No. 38, North Second Lane, Nanhu East Road, Urumqi, Xinjiang Uygur Autonomous Region, Uru

Research on the pathological mechanisms of Parkinson's disease (PD) reveals a significant association between nigrostriatal dopaminergic neuron degeneration and abnormal metabolic networks. However, the substantial increase in clinical heterogeneity complicates early diagnosis and subtyping. Significant progress has been made in recent years through multimodal neuroimaging studies.

View Article and Find Full Text PDF